Skip to main
KIDS

OrthoPediatrics (KIDS) Stock Forecast & Price Target

OrthoPediatrics (KIDS) Analyst Ratings

Based on 9 analyst ratings
Strong Buy
Strong Buy 67%
Buy 22%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

OrthoPediatrics is experiencing a "Super Cycle" of new product launches, leading to strong sales growth and taking market share from competitors. The company has a strong position in the pediatric orthopedic market and a targeted focus on the needs of pediatric patients, setting it apart from larger competitors who have passed on this market opportunity. The company's success in developing and launching new products has been bolstered by a concentrated pipeline and high support from key opinion leaders. With a strong product pipeline and increasing profitability, the company is well-positioned for continued growth and potential multiple expansion.

Bears say

OrthoPediatrics is a young and innovative company, founded in 2006 and focused exclusively on pediatric orthopedics. However, risks to the company's stock and rating include competition from larger, more established orthopedic companies, potential slowdowns in product development, and potential staffing shortages and turnover at customer sites. Furthermore, the company's current portfolio of 46 surgical systems may face competition from larger competitors, which could affect sales and profitability in the future.

OrthoPediatrics (KIDS) has been analyzed by 9 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 22% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of OrthoPediatrics and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About OrthoPediatrics (KIDS) Forecast

Analysts have given OrthoPediatrics (KIDS) a Strong Buy based on their latest research and market trends.

According to 9 analysts, OrthoPediatrics (KIDS) has a Strong Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $26.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $26.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

OrthoPediatrics (KIDS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.